Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 14.61
+0.09 (0.62%)
At close: Jul 31, 2026
Anlon Healthcare Revenue
Anlon Healthcare had revenue of 876.22M INR in the quarter ending June 30, 2026, with 163.15% growth. This brings the company's revenue in the last twelve months to 2.26B, up 95.41% year-over-year. In the fiscal year ending March 31, 2026, Anlon Healthcare had annual revenue of 1.72B with 42.91% growth.
Revenue (ttm)
2.26B
Revenue Growth
+95.41%
P/S Ratio
3.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.72B | 516.33M | 42.91% |
| Mar 31, 2025 | 1.20B | 537.17M | 80.64% |
| Mar 31, 2024 | 666.16M | -464.64M | -41.09% |
| Mar 31, 2023 | 1.13B | 556.91M | 97.04% |
| Mar 31, 2022 | 573.89M | 414.09M | 259.14% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bajaj HealthCare | 6.28B |
| NGL Fine-Chem | 5.01B |
| Aarey Drugs & Pharmaceuticals | 4.72B |
| Sai Parenteral's | 3.81B |
| Gujarat Themis Biosyn | 1.66B |
| Influx Healthtech | 1.47B |
| Kimia Biosciences | 1.15B |
| Shree Ganesh Remedies | 1.09B |